Table 6.
ORa estimates related to death within 30 days from the first positive swab among those who tested positive to SARS-CoV-2 (N=749), stratified by gender and age group (1 model for each variable).
| Variable and category | Male | Female | |||
|
|
Age 45-59 years (n=370, 24.5%), OR (95% CI)b | Age 60-74 years (n=748, 49.6%), OR (95% CI)b | Age 45-59 years (n=133, 8.8%), OR (95% CI)b | Age 60-74 years (n=257, 17.1%), OR (95% CI)b | |
| CCIc | |||||
|
|
0 | Reference | Reference | Reference | Reference |
| 1 | 1.56 (0.89-2.75) | 1.33 (1.02-1.74)d | 2.26 (0.68-7.56) | 1.50 (0.99-2.27) | |
| 2-3 | 5.33 (3.06-9.27)d | 2.24 (1.72-2.91)d | 16.80 (6.35-44.45)d | 2.43 (1.58-3.73)d | |
| 4+ | 17.32 (7.91-37.90)d | 3.26 (2.29-4.64)d | 31.88 (5.96-170.43)d | 5.90 (3.31-10.52)d | |
| Oncological disease | 6.03 (3.00-12.12)d | 1.46 (1.04-2.05)d | 11.03 (3.93-30.96)d | 1.38 (0.77-2.47) | |
| Cardiovascular disease | 3.52 (2.12-5.86)d | 1.56 (1.24-1.95)d | 2.81 (0.82-9.62) | 2.04(1.41-2.94)d | |
| Respiratory disease | 3.89 (2.16-7.02)d | 2.07 (1.54-2.78)d | 5.88 (1.70-20.39)d | 2.92 (1.91-4.45)d | |
| Myocardial infarction | 2.80 (1.15-6.81)d | 1.50 (1.09-2.06)d | N/Ae | 2.16 (1.41-2.94)d | |
| Heart failure | 8.42 (1.66-42.77)d | 1.79 (0.99-3.23) | N/A | 6.04 (2.70-13.53)d | |
| Cerebrovascular disease | 5.68 (2.24-14.36)d | 1.96 (1.38-2.79)d | N/A | 2.06 (1.17-3.65)d | |
| Diabetes | 2.36 (1.34-4.15)d | 1.79 (1.43-2.23)d | 5.72 (2.21-14.79)d | 2.35 (1.64-3.35)d | |
aOR: odds ratio.
bEstimates adjusted for age and the month of the first swab.
cCCI: Charlson Comorbidity Index.
dSignificant estimates (95% confidence level).
eN/A: not applicable.